Amgen Inc (AMGN) Stock Price

AMGNStock

$442.24+51.11%52W

Market Cap$239.09B

P/E29.30x

PEG Ratio2.32

Div yield3.21%

Beta0.41

AMGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)5.64%

Price vs S&P 500 (4W)9.86%

PEG Ratio2.32

VGM Score57.44

P/E Ratio (Annual)29.30x

Indicated Dividend Yield (Annual)3.21%

P/CF (Annual)22.68x

Book Value / Share (Quarterly)$21.60

P/TBV (Annual)24.53x

Indicated Dividend (Annual)$10.08

Revenue Growth (3Y)11.77%

Cash Flow / Share (Quarterly)$19.76

Payout Ratio (TTM)66.71%

Price vs S&P 500 (YTD)23.64%

Gross Margin (TTM)74.30%

Net Profit Margin (TTM)22.95%

EPS (TTM)$16.10

10-Day Avg Trading Volume2.44M

EPS Excl Extra (TTM)$16.10

Revenue Growth (5Y)7.65%

EPS (Annual)$14.23

Dividend / Share (Annual)$9.53

ROI (Annual)12.19%

Gross Margin (Annual)70.78%

Net Profit Margin (5Y Avg)20.92%

Cash / Share (Quarterly)$25.86

P/E Basic Excl Extra (TTM)25.84x

Revenue Growth QoQ (YoY)9.53%

EPS Growth (5Y)2.93%

P/E Normalized (Annual)29.30x

ROA (Last FY)8.51%

Revenue Growth TTM (YoY)9.10%

EBITD / Share (TTM)$27.82

ROE (5Y Avg)106.67%

Operating Margin (TTM)30.32%

Cash Flow / Share (Annual)$15.03

P/B Ratio19.33x

P/B Ratio (Quarterly)16.72x

Net Income / Employee (Annual)$244,800

EV / Revenue (TTM)7.07x

Net Interest Coverage (TTM)12.70x

ROA (TTM)9.48%

EPS Growth QoQ (YoY)64.93%

EV / EBITDA (TTM)17.82x

EPS Incl Extra (Annual)$14.23

Current Ratio (Annual)1.14x

Quick Ratio (Quarterly)1.13x

3-Month Avg Trading Volume2.69M

52-Week Price Return51.11%

EV / Free Cash Flow (Annual)33.24x

P/E Incl Extra (TTM)25.84x

Revenue / Employee (TTM)$1,209,400

Tangible BV / Share (Quarterly)$7.09

P/S Ratio (Annual)6.15x

Asset Turnover (Annual)0.41x

52-Week High$445.87

Operating Margin (5Y Avg)28.53%

EPS Excl Extra (Annual)$14.23

CapEx CAGR (5Y)25.03%

Tangible BV CAGR (5Y)-10.56%

26-Week Price Return16.88%

Quick Ratio (Annual)0.78x

13-Week Price Return31.54%

Total Debt / Equity (Annual)6.31x

Current Ratio (Quarterly)1.37x

Enterprise Value$269.21B

Revenue / Share Growth (5Y)9.49%

Asset Turnover (TTM)0.41x

Book Value / Share Growth (5Y)-0.25%

Revenue / Employee (Annual)$1,166,700

Inventory Turnover (Annual)1.62x

Pretax Margin (Annual)24.42%

Cash / Share (Annual)$16.94

3-Month Return Std Dev26.98%

Gross Margin (5Y Avg)72.09%

Net Income / Employee (TTM)$277,600

EBITDA CAGR (5Y)2.64%

EBITDA Interim CAGR (5Y)15.86%

ROE (Last FY)89.06%

Net Interest Coverage (Annual)3.32x

EPS Basic Excl Extra (Annual)$14.23

P/FCF (TTM)21.14x

Receivables Turnover (TTM)4.03x

EV / Free Cash Flow (TTM)25.19x

Total Debt / Equity (Quarterly)4.90x

EPS Incl Extra (TTM)$16.10

Receivables Turnover (Annual)4.50x

ROI (TTM)13.30%

Dividend Growth Rate (5Y)8.21%

P/S Ratio (TTM)5.93x

Pretax Margin (5Y Avg)23.95%

Revenue / Share (Annual)$67.81

Tangible BV / Share (Annual)$8.03

Forward P/E16.86x

Free OCF CAGR (5Y)-3.91%

Price vs S&P 500 (52W)32.80%

P/E Ratio (TTM)25.84x

EPS Growth TTM (YoY)31.72%

Year-to-Date Return35.60%

5-Day Price Return4.36%

EPS Normalized (Annual)$14.23

ROA (5Y Avg)7.91%

Net Profit Margin (Annual)20.98%

Month-to-Date Return15.24%

Cash Flow / Share (TTM)$20.77

EBITD / Share (Annual)$26.77

EPS Growth (3Y)5.51%

Operating Margin (Annual)25.43%

LT Debt / Equity (Annual)5.78x

P/CF (TTM)18.10x

ROI (5Y Avg)11.60%

P/E Excl Extra (TTM)25.84x

LT Debt / Equity (Quarterly)4.44x

EPS Basic Excl Extra (TTM)$16.10

P/TBV (Quarterly)27.47x

Payout Ratio (Annual)66.45%

P/B Ratio (Annual)20.36x

Dividend / Share (TTM)$9.66

Inventory Turnover (TTM)1.53x

Pretax Margin (TTM)27.00%

Book Value / Share (Annual)$16.07

Price vs S&P 500 (13W)28.75%

Net Margin Growth (5Y)-5.99%

Dividend Yield (TTM)2.30%

Beta0.41x

P/FCF (Annual)27.89x

Revenue / Share (TTM)$70.03

ROE (TTM)89.32%

52-Week Low$269.77

vGradeC

gGradeC

mGradeB

vgmGradeC

AMGN Earnings Surprise History

Q2 256.02est. 5.28

Q3 255.64est. 5.01

Q4 255.29est. 4.73

Q1 265.15est. 4.77

Q2 266.29est. 5.62

AMGN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.52

3.55

3.53

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	$14.56

About Amgen Inc

Amgen is a leading global biotechnology company with a diversified portfolio spanning oncology, cardiovascular disease, immunology, inflammation, and rare diseases. The company has expanded through strategic acquisitions including Onyx Pharmaceuticals and Horizon Therapeutics, while building a growing biosimilar business alongside marketed drugs across multiple therapeutic franchises. Recent launches demonstrate continued innovation in areas including cardiovascular health, migraine, oncology, and immunology.